Anticancer Therapies – Multimedia

Find out about why there is so much excitement about this new therapy, which patients are the best candidates, as well as CAR T-cell effectiveness, safety, and costs.

Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., winner of the 2018 Nobel Prize in Physiology or Medicine, we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.

Nanoparticles are capable of carrying chemotherapy to areas of the body afflicted by cancer. However, what if these nanoparticles were specifically targeted to treat only cancer cells and not healthy cells?

Tremendous progress has been made in the cancer research field over the past 20 years. This infographic highlights 10 major milestones since the year 2000.

This list highlights ten major milestones within the field of cancer research since the year 2000.

Download this application note to learn about a novel assay that was used to evaluate a library of kinase inhibitors by simultaneously measuring activation markers, cell proliferation and cytokines.

A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer.

Cancer vaccines are a type of immunotherapy and can take two forms. Cancer prevention vaccines may be given to healthy people to help destroy certain viruses that could lead to cancer. Cancer treatment vaccines teach the immune system how to attack an existing cancer and keep it from coming back.

Epigenetics is the science of what turns genes on and off. We know that mutations or damaged genes in our DNA can lead to cancer. Researchers are working on epigenetic drugs that conflict the on/off switches on our genes to change the instructions that cancer cells are following.

Download this application note to learn about a novel assay that was used to simultaneously evaluate T cell activation markers, cell proliferation, and cytokines